血清肿瘤标志物在2型糖尿病合并骨量异常患者中意义的研究

目的探讨2型糖尿病（type 2 diabetes,T2DM）患者血清中肿瘤标志物与骨密度（bone mineral density,BMD）的关系。方法随机纳入2014年2月至2015年12月就诊于石河子大学医学院第一附属医院内分泌科的T2DM患者240例,根据双能X线骨密度检查结果将研究对象分为T2DM并骨量正常组,T2DM并骨量减低组,T2DM并骨质疏松组,分别比较不同组肿瘤标志物及分析相关因素与骨量的关系。结果①与骨量正常组相比,骨量减少组的FPG升高（P〈0.05）,与骨量正常组相比,骨质疏松组中的FPG升高（P〈0.01）,与骨量正常组相比,骨质疏松组中的HbAlc升高（P〈0.0...

Full description

Saved in:
Bibliographic Details
Published in中国骨质疏松杂志 Vol. 23; no. 12; pp. 1569 - 1573
Main Author 赵丽颖;李军;李思源;阳毅;蔺茹君;孙侃
Format Journal Article
LanguageChinese
Published 新疆石河子大学医学院第一附属医院内分泌代谢科,新疆石河子,832000%石河子大学医学院,新疆石河子,832000%四川德阳市人民医院,四川德阳,618000 2017
Subjects
2型糖尿病
CA199
肿瘤标志物
骨密度
骨质疏松症
Tumor marker
Osteoporosis
骨密度
Bone mineral density
骨质疏松症
Type 2 diabetes mellitus
CA199
肿瘤标志物
2型糖尿病
Online AccessGet full text
ISSN1006-7108
DOI10.3969/j.issn.1006-7108.2017.12.007

Cover

More Information
Summary:目的探讨2型糖尿病（type 2 diabetes,T2DM）患者血清中肿瘤标志物与骨密度（bone mineral density,BMD）的关系。方法随机纳入2014年2月至2015年12月就诊于石河子大学医学院第一附属医院内分泌科的T2DM患者240例,根据双能X线骨密度检查结果将研究对象分为T2DM并骨量正常组,T2DM并骨量减低组,T2DM并骨质疏松组,分别比较不同组肿瘤标志物及分析相关因素与骨量的关系。结果①与骨量正常组相比,骨量减少组的FPG升高（P〈0.05）,与骨量正常组相比,骨质疏松组中的FPG升高（P〈0.01）,与骨量正常组相比,骨质疏松组中的HbAlc升高（P〈0.05）,与骨量正常组相比,骨量减少组和骨质疏松组中的FINS、HOMA-IR、HOMA-IS降低（P〈0.01）。②与骨量正常组相比,骨质疏松组CA199升高（P〈0.01）。③BMD（股骨颈）与血清CA199呈负相关（r=-0.192,P〈0.01）。④以CA199为因变量,年龄、体重、病程、BMI、FPG、HbAlc、FINS、HOMA-IR、HOMA-IS、BMD（股骨颈）为自变量做回归分析,BMD（股骨颈）（P=0.021,t=-2.328）进入回归方程,Y=34.674-22.65X。结论血清CA199在2型糖尿病合并骨质疏松组患者中升高,且在2型糖尿病患者中BMD越低,CA199水平越高。
Bibliography:Objective To investigate the relationship between serum tumor markers and bone mineral density （BMD） in patients with type 2 diabetes mellitus （T2DM）. Methods Study participants were T2DM patients who were recruited from the Department of Endocrinology of the First Affiliated Hospital of Shihezi University from February 2014 to December 2015. According to the results of dual energy X-ray absorptiomentry BMD examination, the subjects were divided into T2DM and normal bone mass group, T2DM and Osteopenia group, T2DM and osteoporosis group, respectively, to compare tumor markers between the groups of and analyze the relationship between relevant factors and bone mass. Results 1.Compared with the normal bone mass group, the osteopenia group had higher levels of fasting plasma glucose （P 〈 0.05）. Compared with the normal bone mass group, the osteoporosis group had higher levels of fasting plasma glucose （P 〈0.01）. Compared with the normal bone mass group, the osteoporosis group had higher levels of HbAlc （P 〈0.05）
ISSN:1006-7108
DOI:10.3969/j.issn.1006-7108.2017.12.007